Regulus Therapeutics

+$0.0133 (+6.43%) As of 8:24 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RGLS and other ETFs, options, and stocks.

About RGLS

Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development.

CEO
Joseph P. Hagan
Employees
24
Headquarters
San Diego, California
Founded
2007

RGLS Key Statistics

Market cap
30.23M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.34M
High today
$0.227
Low today
$0.2068
Open price
$0.21
Volume
1.32M
52 Week high
$2.32
52 Week low
$0.19

RGLS Earnings

-$0.23
-$0.15
-$0.08
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure